ArticleAddiction (Abingdon, England)2020
Estimation of the proportion of population cannabis consumption in Australia that is accounted for by daily users using Monte Carlo Simulation.
Article in Addiction (Abingdon, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 39 citations in OpenAlex.
- Does the total consumption model apply to cannabis use?Addiction (Abingdon, England) · 2026Article
- Differentiating people who use cannabis heavily through latent class analysis.Substance abuse treatment, prevention, and policy · 2023Article
- Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.Harm reduction journal · 2023Article
- Trends in cannabis use intention around the period of cannabis legalisation in Australia: An age-period-cohort model.Drug and alcohol review · 2023Article
- Characteristics of the Washington cannabis market from 2014 to 2016.Journal of cannabis research · 2022Article
- The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use.Addiction (Abingdon, England) · 2022Article
- Estimating Usual Grams per Day of Marijuana Use from Purchases.Addiction research & theory · 2022Article
- Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.Frontiers in public health · 2022Article
- Do Cannabis Users Reduce Their THC Dosages When Using More Potent Cannabis Products? A Review.Frontiers in psychiatry · 2021Review
- The costs and benefits of cannabis control policies .Dialogues in clinical neuroscience · 2020Review
- Commentary on Chan & Hall (2020): Advances in specifying cannabis consumption.Addiction (Abingdon, England) · 2020Article
- Cannabis and COVID-19: Reasons for Concern.Frontiers in psychiatry · 2020Article
Corrections and comments
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo estimate the proportion of cannabis consumed in Australia by daily cannabis users.
designMonte Carlo simulation using parameters estimated from nationally representative and repeated cross-sectional household surveys in 2007, 2010, 2013 and 2016.
settingAustralia
participantsAdult samples (mean age = 49.9; 55% females) from four National Drug Strategy Household Surveys (n = 92 243). MEASUREMENT: Frequency of cannabis use (daily/weekly/about once a month/every few months/once or twice a year). The weighted estimated prevalence of users in each of these frequency levels was multiplied by population size to estimate the total number of users. Quantity of cannabis use was measured as number of joints consumed. The consumption of those who reported using bongs was converted into joints based on the bong to joint ratio estimated from the survey data. We estimated the proportion of cannabis consumed by daily users by Monte Carlo simulation using parameters estimated from the household surveys. We conducted 10 000 simulation trials, and in each trial we [1] simulated the number of users at each consumption level (stratum) based on estimated prevalence and population size[2], for each simulated individual, we simulated the number of days of cannabis use in a year based on frequency data[3], for each consumption day, we simulated the quantity consumed [4] and lastly we calculated the total joints consumed at each consumption level and estimated the proportion of joints consumed by daily users out of the total consumption.
findingsThe prevalence of past-year cannabis use increased from 8.9% [95% confidence interval (CI) = 8.5-9.4] in 2007 to 10.5% (95% CI = 10.0-11.1) in 2016, 16% of whom were daily users. Between 2007 and 2016, daily users accounted for between 81.6 and 85.7% of all cannabis consumed. Weekly users accounted for an additional 12.1-15.9%.
conclusionBetween 2007 and 2016, only one in six Australian cannabis users were daily users, but they accounted for more than 80% of the estimated cannabis consumed in Australia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.